One recently published genome-wide association study (GWAS), investigating the associations between cisplatin-induced AKI and genetic variants across the whole genome, identified five novel variants in a cohort of adult cancer patients, including a variant in BACH2 that was also statistically significantly associated in a second validation cohort [41]. Here, BACH2 is linked to cancer.